Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration
(NASDAQ: ALLR) Delayed: 1.25 -0.17 (11.97%)
Previous Close $1.42    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.37    P/E N/A 
Day Low $1.25    EPS $ 
Volume 236,772       

(NASDAQ: ALLR) Delayed: 1.25 -0.17 (11.97%)
Previous Close $1.42    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.37    P/E N/A 
Day Low $1.25    EPS $ 
Volume 236,772